DCX and stroke disorder: Brain sections were co-stained for BrdU/SOX2 (the recognized phenotypic marker for NSCs) and BrdU/DCX (the neuroblast marker) in the SVZ at 35 days after stroke to identify the proliferating and migrating cells, respectively (Figure 5).